1. Home
  2. FBIO vs IRIX Comparison

FBIO vs IRIX Comparison

Compare FBIO & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.71

Market Cap

90.7M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.69

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIO
IRIX
Founded
2006
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.7M
15.0M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
FBIO
IRIX
Price
$2.71
$0.69
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
523.9K
91.2K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
97.40
51.85
EPS
2.86
N/A
Revenue
$63,262,000.00
$41,593,000.00
Revenue This Year
$55.22
$3.07
Revenue Next Year
$40.55
$6.66
P/E Ratio
$0.95
N/A
Revenue Growth
9.69
N/A
52 Week Low
$2.18
$0.69
52 Week High
$4.53
$1.65

Technical Indicators

Market Signals
Indicator
FBIO
IRIX
Relative Strength Index (RSI) 42.16 30.33
Support Level $2.70 N/A
Resistance Level $3.02 $1.14
Average True Range (ATR) 0.11 0.04
MACD 0.00 0.00
Stochastic Oscillator 23.60 8.68

Price Performance

Historical Comparison
FBIO
IRIX

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: